Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03116022Phase 1Completed
Phase 1, randomised, single-blind trial of estriol in dyspareunia (3 arms), sponsored by Universidade de São Paulo. Primary endpoint: Improvement in pain score at 12 weeks. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03116022.